600739 Stock Overview
Engages in supply chain trade, biopharmaceuticals, financial investment, energy development, and other businesses in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Liaoning Cheng Da Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.58 |
| 52 Week High | CN¥12.95 |
| 52 Week Low | CN¥7.13 |
| Beta | 0.84 |
| 11 Month Change | 44.57% |
| 3 Month Change | 36.88% |
| 1 Year Change | -10.58% |
| 33 Year Change | -54.69% |
| 5 Year Change | -13.19% |
| Change since IPO | -30.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600739 | CN Trade Distributors | CN Market | |
|---|---|---|---|
| 7D | 10.0% | 8.9% | 9.9% |
| 1Y | -10.6% | -8.0% | 1.2% |
Return vs Industry: 600739 underperformed the CN Trade Distributors industry which returned -8% over the past year.
Return vs Market: 600739 underperformed the CN Market which returned 1.2% over the past year.
Price Volatility
| 600739 volatility | |
|---|---|
| 600739 Average Weekly Movement | 5.8% |
| Trade Distributors Industry Average Movement | 6.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 4.5% |
Stable Share Price: 600739 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600739's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3,356 | Yu Ge | www.chengda.com.cn |
Liaoning Cheng Da Co., Ltd. engages in supply chain trade, biopharmaceuticals, financial investment, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles and clothing, as well as trading of bulk commodities, such as coal, steel, and aquatic and agricultural products; and investment in securities, insurance and funds, and other financial service enterprises. It also offers human rabies vaccine and human JE inactivated vaccines, as well as exports its products to Egypt and Thailand; and engages in the investment in medical industry, and medical enterprise management consulting.
Liaoning Cheng Da Co., Ltd. Fundamentals Summary
| 600739 fundamental statistics | |
|---|---|
| Market cap | CN¥17.63b |
| Earnings (TTM) | CN¥195.93m |
| Revenue (TTM) | CN¥11.50b |
90.0x
P/E Ratio1.5x
P/S RatioIs 600739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600739 income statement (TTM) | |
|---|---|
| Revenue | CN¥11.50b |
| Cost of Revenue | CN¥9.97b |
| Gross Profit | CN¥1.52b |
| Other Expenses | CN¥1.33b |
| Earnings | CN¥195.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 31, 2024
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 13.26% |
| Net Profit Margin | 1.70% |
| Debt/Equity Ratio | 44.8% |
How did 600739 perform over the long term?
See historical performance and comparison